Enrolling Studies

Axiom is currently enrolling patients in Multiple Sclerosis, Alzheimer’s Disease and Migraine studies.

If you or a loved one would be interested in participating in a study for any of the listed fields, or if you would like more information on our studies, please contact us at  or 813-353-9613.

CURRENTLY ENROLLING STUDIES

• Agitation treatment in subjects with Dementia of the Alzheimer’s Type

• Phase 3 treatment for the prevention of migraine in participants with episodic migraine

• Phase 2 study in patients with Lewy Body Dementia or Idiopathic Parkinson's Disease

• Phase III Study of Evobrutinib in RMS

• Oral treatment with FDA approved medication for Multiple Sclerosis 

UPCOMING STUDIES